• Propranolol Modulates Burn-Induced Metabolic Pathways: RCT I

  2026-04-25

  This randomized controlled trial demonstrates that propranolol treatment in severely burned patients significantly normalizes key metabolic and lipidomic pathways in adipose tissue, shifting the profile towards an anti-inflammatory state and improving clinical outcomes. These findings elucidate the mechanistic basis for propranolol’s benefits in burn care and inform future metabolic intervention strategies.

• H-89: Optimizing cAMP-Dependent Protein Kinase Inhibition Wo

  2026-04-24

  H-89 from APExBIO is the gold-standard cAMP-dependent protein kinase inhibitor for dissecting cAMP signaling in metabolic, osteogenic, and cell proliferation studies. This guide bridges the latest mechanistic insights with actionable protocols and troubleshooting strategies, empowering researchers to achieve reproducible, high-specificity results.

• Applied Workflows with Recombinant Human EGF: Precision and

  2026-04-24

  Recombinant human EGF empowers advanced cell migration, proliferation, and mucosal healing studies with unmatched consistency. This article delivers protocol-driven guidance, troubleshooting insights, and workflow enhancements that set APExBIO’s EGF apart in translational research.

• HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody: Practic

  2026-04-23

  The HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody addresses the need for reliable, high-sensitivity fluorescent detection of rabbit primary antibodies in immunofluorescence, flow cytometry, and microscopy workflows. It is best suited for protocols requiring robust signal amplification and minimal cross-reactivity, but should not be used outside validated immunoassay contexts or with non-rabbit primaries.

• Substance P (B6620): Technical Guidance for CNS and Immunoas

  2026-04-23

  Substance P enables precise modeling of pain transmission, inflammation, and immune response modulation in CNS-focused research. This product is best suited for applications requiring a high-purity tachykinin neuropeptide with well-characterized solubility and receptor targeting properties. It should not be used for diagnostic or therapeutic purposes or in workflows demanding long-term solution stability.

• Recombinant Human Growth Hormone: Advanced Cell Assay Workfl

  2026-04-22

  Unlock the full potential of Recombinant Human Growth Hormone (GH) in cell proliferation and mechanistic signaling studies. This guide delivers actionable protocols, troubleshooting insights, and the latest mechanistic breakthroughs to optimize GH-driven research workflows.

• Structure-Based Screening Reveals NSP15 Inhibitors for SARS-

  2026-04-22

  This study leverages structure-based virtual screening to identify natural product inhibitors targeting NSP15, a key endoribonuclease implicated in immune evasion by SARS-CoV-2. The work highlights thymopentin and oleuropein as potent and stable binders, providing a foundation for future antiviral development.

• Balancing Self-Renewal and Differentiation in Human Intestin

  2026-04-21

  This study introduces a tunable human intestinal organoid system that achieves a controlled balance between stem cell self-renewal and differentiation using small molecule modulators. The approach enhances cellular diversity and proliferative capacity, addressing longstanding challenges in organoid model scalability and utility for disease modeling and high-throughput screening.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor–S

  2026-04-21

  This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids and stromal cell subpopulations, capturing microenvironmental complexity absent from standard organoid systems. The platform enables more physiologically relevant drug screening, reveals resistance mechanisms, and supports the advancement of personalized therapeutic strategies.

• Ionomycin Calcium Salt: Unraveling Calcium Ionophore Pathway

  2026-04-20

  Explore the dual role of Ionomycin calcium salt as a calcium ionophore in modulating intracellular Ca2+ and disrupting cancer cell survival via ribosome biogenesis pathways. This article offers a unique, evidence-based analysis bridging calcium signaling and translational oncology.

• 5-Azacytidine in Multiple Myeloma: Mechanistic Insights & Pr

  2026-04-20

  Explore how 5-Azacytidine acts as a DNA demethylation agent and apoptosis inducer in multiple myeloma research. This article uniquely dissects ATR-mediated DNA damage mechanisms and provides actionable protocol guidance for advanced cancer biology studies.

• Trelagliptin Promotes Osteoblastic Differentiation via RUNX2

  2026-04-19

  This study reveals that trelagliptin, a DPP-4 inhibitor, enhances osteoblastic differentiation in MC3T3-E1 cells by increasing RUNX2 expression through the AMPK pathway. These findings suggest a novel therapeutic potential for trelagliptin in osteoporosis, with implications for bone metabolic research.

• Reserpine (SKU N1867): Technical Guidance for Lab Research

  2026-04-18

  Reserpine is a high-purity alkaloid suited for neurotransmitter depletion, antihypertensive mechanism studies, and neuropharmacology workflows. This article provides actionable parameters and workflow recommendations for researchers using Reserpine in experimental setups, with clear boundaries on applicability. It is not intended for diagnostic or clinical use.

• Macrophage EV-miR-660 Drives Breast Cancer via KLHL21/NF-κB

  2026-04-17

  This study uncovers how tumor-associated macrophage-derived extracellular vesicles, enriched in microRNA-660, promote breast cancer metastasis by targeting KLHL21 and activating the NF-κB p65 pathway. The findings refine our understanding of stromal-tumor crosstalk and offer mechanistic insights relevant to signaling pathway intervention.

• Fucoidan in Cancer & Immunology: Applied Protocols and Insig

  2026-04-16

  Harness the multifaceted power of Fucoidan, a sulfated α-L-fucan, for advanced cancer and immunology research. This article delivers actionable workflows, protocol optimizations, and troubleshooting strategies to maximize reproducibility, leveraging APExBIO’s high-purity Fucoidan as a robust platform for translational innovation.

16861 records 1/1125 page Next 12345 下5页 Last page